Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
5.32
+0.22 (4.31%)
At close: Apr 28, 2026, 4:00 PM EDT
5.23
-0.09 (-1.69%)
Pre-market: Apr 29, 2026, 4:58 AM EDT
Enveric Biosciences Employees
As of December 31, 2025, Enveric Biosciences had 6 total employees, including 5 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
6
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,021,912
Market Cap
10.56M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| CytoMed Therapeutics | 43 |
| Lunai Bioworks | 29 |
| Imunon | 25 |
| Bolt Biotherapeutics | 23 |
| CalciMedica | 16 |
| Kiora Pharmaceuticals | 13 |
| Genprex | 13 |
ENVB News
- 21 hours ago - Lakewood-Amedex Biotherapeutics Appoints Joseph Tucker, Ph.D., to Board of Directors - PRNewsWire
- 4 days ago - What's Going On With Enveric Biosciences Stock On Friday? - Benzinga
- 7 days ago - Enveric Biosciences to Participate in a Panel Discussion at Needham's Virtual Psychedelics Forum - Business Wire
- 8 days ago - Enveric Biosciences Stock Soars After Trump's Psychedelics Executive Order - Benzinga
- 8 days ago - Psychedelic drug makers rally as Trump orders FDA to expedite reviews - Reuters
- 11 days ago - Enveric Biosciences Announces Closing of Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Business Wire
- 12 days ago - Enveric Biosciences Announces Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Business Wire
- 4 weeks ago - Enveric Biosciences Secures New U.S. Patent for Its EVM301 Series of Drug Candidates - Business Wire